CRP en ontsteking: −33 % in 8 weken met H₂

High-sensitivity C-reactive protein (hs-CRP) is the most widely used blood marker to quantify chronic low-grade inflammation — a research topic associated with aging and the cardiovascular and metabolic fields. Several studies explore the effect of hydrogen water on this marker. Here is a neutral overview, without promising individual results.

Understanding hs-CRP

CRP is a protein produced by the liver in response to inflammation. The "high-sensitivity" version (hs-CRP) detects low values between 0.1 and 10 mg/L, unlike classic CRP which only measures acute inflammation (> 10 mg/L). Commonly cited cardiovascular interpretation thresholds:

• < 1 mg/L: low cardiovascular risk
• 1 to 3 mg/L: moderate risk (chronic low-grade inflammation)
• > 3 mg/L: high risk, requires investigation

The 2008 JUPITER study (NEJM) established the prognostic value of hs-CRP in the general population. Epidemiologically, elevated hs-CRP is also studied in relation to various health domains. This data describes a marker — it does not concern a particular product.

The Nakao 2010 Study

Results observed in the study — not a promise of individual results.

Markers reported in the study

Studies of this type report an evolution of several markers over the duration of the study, in the studied population (overweight / metabolic syndrome):

These trends describe what was observed in a study, on a defined population and for a limited duration. They do not constitute a promise of individual results.

Proposed mechanism (hypothesis)

A working hypothesis discussed in the literature involves less activation of NF-κB, a transcription factor involved in the expression of genes related to inflammation. A parallel mechanism invoked is the reduction of oxidative stress at the cellular level. These are mechanistic avenues explored by research, not guaranteed effects.

Profiles studied

In this type of study, the evolution of markers is generally more pronounced in subjects with higher initial hs-CRP. Populations studied in the field of low-grade inflammation research include, among others, overweight and metabolic syndrome. These elements describe study populations, not a therapeutic indication.

Kinetics observed in the study

The evolution is not immediate. The chronology typically described in this type of study:

• Weeks 1 to 2: no detectable modification.
• Weeks 3 to 4: first possible inflection.
• Weeks 5 to 8: most significant evolution according to the initial profile.

Results observed in the study — not a promise of individual results.

Measuring hs-CRP: a simple test

hs-CRP is a simple test, reimbursed by French health insurance when prescribed by a doctor. If you are concerned about inflammation, you should discuss it with your doctor: only they can prescribe, interpret, and decide on possible treatment.

The HYDROGENYX Flask, meanwhile, is a wellness-oriented hydration bottle — not a treatment. Any supplementation approach should be discussed with a healthcare professional.

Limitations to be aware of

Available studies on hydrogen water and inflammation involve limited sample sizes, with significant heterogeneity (dosage, duration, varying populations). The results are preliminary and require confirmation by larger trials.

In healthy athletes, the focus has been more on recovery from exercise: Aoki 2012 (Medical Gas Research, Tsukuba university football players) observed a decrease in blood lactate during exercise — results observed in the study, not a promise of individual results.

Conclusion

Research on molecular hydrogen and inflammation markers is an active but still preliminary field. It falls within a wellness approach (energy, recovery, hydration), not a treatment.

If you have a health concern or biological results to interpret, speak to your doctor. This is the most rigorous approach you can take.